Market Research Logo

Branded Generics Market: Oncology Therapeutic Application Segment Expected to Grow Significantly in Developed Markets over the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016 –2026

Branded Generics Market: Oncology Therapeutic Application Segment Expected to Grow Significantly in Developed Markets over the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016 –2026

Increasing prevalence of chronic and lifestyle diseases expected to create demand for branded generics over the assessment period

The global branded generics market was valued at more than US$ 190 Bn in 2015 and is expected to witness a 7.3% CAGR over the forecast period (2016–2026). The market is projected to be valued at more than US$ 410 Bn by 2026. The global branded generics market is expected to represent incremental opportunity of nearly US$ 220 Bn between 2016 and 2026. Rising number of comorbidities like diabetes and cardiovascular diseases is creating ample opportunities for new and existing players in the global branded generics market.

Global Branded Generics Market Value (US$ Bn) By Therapeutic Application, 2016-2026

Cardiovascular diseases application segment expected to hold a large market revenue share over the projected period

The cardiovascular diseases segment was estimated to account for 11.8% market share of the global branded generics market by 2016 end and is expected to gain 102 BPS by 2026 over 2016. Cardiovascular diseases segment is expected to register high Y-o-Y growth throughout the forecast period. The segment was expected to reach a value of nearly US$ 25 Bn by 2016 end and is projected to remain the dominant segment during the forecast period. The dermatology diseases segment is expected to register moderate Y-o-Y growth as compared to other segments throughout the forecast period. Revenue contribution of this segment to the global branded generics market is expected to increase at a CAGR of 6.0% over the forecast period. In terms of value, the cardiovascular diseases segment is expected to register the highest CAGR of 8.2% during the assessment period. The neurology and dermatology diseases segments are expected to remain the least attractive segments in the global branded generics market in revenue terms with an attractive index of 0.5 each over the forecast period.

Diabetes segment market revenue share projected to grow at a significant CAGR owing to increasing prevalence of diabetes in Asia Pacific and MEA regions

The Diabetes segment is estimated to create absolute $ opportunity of US$ 1.6 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 7.7% from 2016 to 2026 to reach a value of nearly US$ 45 Bn by 2026. The Oncology segment is estimated to create absolute $ opportunity of US$ 1.1 Bn in 2017 over 2016. Revenue from this segment is projected to exhibit a CAGR of 6.9% from 2016 to 2026 to reach a value of more than US$ 30 Bn by 2026. The Neurology segment is estimated to create absolute $ opportunity of US$ 0.8 Bn in 2017 over 2016. Revenue from this segment is projected to register a CAGR of 6.1% from 2016 to 2026 to reach a value of about US$ 25.0 Bn by 2026. The Analgesics and Anti-inflammatory segment is estimated to create absolute $ opportunity of US$ 0.9 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 6.6% from 2016 to 2026 to reach a value of nearly US$ 30 Bn by 2026. Increasing out-of-pocket healthcare expenditure and patent expiries of blockbuster drugs fuelling the global branded generics market

As per Future Market Insights analysis, emerging economics such as Brazil, Russia, India and China are the most lucrative markets for branded generics. A big aspect that is fuelling the global branded generics market is the increasing out-of-pocket expenditure on healthcare in both emerging and developed economies. In addition, patent expiries of blockbuster drugs is also positively impacting the global branded generics market. Analysts working on this report have noticed a trend of mergers and acquisitions amongst the key market players to help consolidate their position in the global branded generics market.


1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Generics Market Overview
3. Global Branded Generics Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
3.2.1. Value Chain
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors – Relevance and Impact
4.7.Regulations
4.8.Porter Five Forces Model
4.9.Patennt expiries in 2016
5. Global Branded Generics Market Analysis and Forecasts, By Therapeutic Application Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Therapeutic Application Type
5.3. Y-o-Y Growth Projections By Therapeutic Application Type
5.4. Market Value Forecast By Therapeutic Application Type , 2016–2026
5.4.1. Oncology
5.4.2. Cardiovascular Diseases
5.4.3. Diabetes
5.4.4. Neurology
5.4.5. Gastrointestinal Diseases
5.4.6. Dermatology Diseases
5.4.7. Analgesics and Anti-inflammatory
5.4.8. Others
5.5. Prominent Trends
5.6. Market Attractiveness By Therapeutic Application Type
6. Global Branded Generics Market Analysis and Forecasts, By Distribution Channel
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Distribution Channel
6.3. Y-o-Y Growth Projections By Distribution Channel
6.4. Market Value Forecast By Distribution Channel, 2016–2026
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.4.4. Drug Stores
6.5. Prominent Trends
6.6. Market Attractiveness By Distribution Channel
7. Global Branded Generics Market Analysis and Forecasts, By Major Drug Classes
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Major Drug Classes
7.3. Y-o-Y Growth Projections By Major Drug Classes
7.4. Market Value Forecast By Major Drug Classes, 2016–2026
7.4.1. Alkylating Agents
7.4.2. Antimetabolites
7.4.3. Hormones
7.4.4. Anti-Hypertensive
7.4.5. Lipid Lowering Drugs
7.4.6. Anti-Depressants
7.4.7. Anti-Psychotics
7.4.8. Anti-Epileptic
7.4.9. Others
7.5. Prominent Trends
7.6. Market Attractiveness By Major Drug Classes
8. Global Branded Generics Market Analysis and Forecasts, By Formulation Type
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Formulation Type
8.3. Y-o-Y Growth Projections By Formulation Type
8.4. Market Value Forecast By Formulation Type , 2016–2026
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.4.4. Others
8.5. Prominent Trends
8.6. Market Attractiveness By Formulation Type
9. Global Branded Generics Market Analysis and Forecasts, By Region
9.1. Basis Point Share (BPS) Analysis By Region
9.2. Y-o-Y Growth Projections By Region
9.3. Market Value Forecast By Region
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. APEJ
9.3.6. Japan
9.3.7. MEA
9.4. Market Attractiveness By Region
10. North America Branded Generics Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2.Market Value Forecast By Therapeutic Application Type , 2016–2026
10.2.1. Oncology
10.2.2. Cardiovascular Diseases
10.2.3. Diabetes
10.2.4. Neurology
10.2.5. Gastrointestinal Diseases
10.2.6. Dermatology Diseases
10.2.7. Analgesics and Anti-inflammatory
10.2.8. Others
10.3.Market Value Forecast By Distribution Channel, 2016–2026
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.3.4. Drug Stores
10.4.Market Value Forecast By Major Drug Classes, 2016–2026
10.4.1. Alkylating Agents
10.4.2. Antimetabolites
10.4.3. Hormones
10.4.4. Anti-Hypertensive
10.4.5. Lipid Lowering Drugs
10.4.6. Anti-Depressants
10.4.7. Anti-Psychotics
10.4.8. Anti-Epileptic
10.4.9. Others
10.5.Market Value Forecast By Formulation Type , 2016–2026
10.5.1. Oral
10.5.2. Parenteral
10.5.3. Topical
10.5.4. Others
10.6.Market Value Forecast By Country, 2016–2026
10.6.1. US
10.6.2. Canada
10.7.Market Attractiveness Analysis
10.7.1. By Therapeutic Application Type
10.7.2. By Distribution Channel
10.7.3. By Major Drug Classes
10.7.4. By Formulation Type
10.7.5. By Country
10.8. Prominent Trends
10.9. Drivers and Restraints: Impact Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report